Seres Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Seres Therapeutics (MCRB) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Seres Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Seres Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Seres Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $31k | 39k | 0.77 |
| 2023-12-31 | $92k | 66k | 1.40 |
| 2023-09-30 | $342k | 144k | 2.38 |
| 2023-06-30 | $671k | 140k | 4.79 |
| 2023-03-31 | $3.0M | 525k | 5.63 |
| 2022-12-31 | $3.4M | 613k | 5.63 |
| 2022-06-30 | $2.7M | 781k | 3.49 |
| 2022-03-31 | $1.0M | 142k | 7.18 |
| 2021-12-31 | $303k | 36k | 8.44 |
| 2021-03-31 | $2.9M | 143k | 20.37 |
| 2020-12-31 | $3.9M | 155k | 25.08 |
| 2020-09-30 | $5.0M | 175k | 28.68 |
| 2020-06-30 | $4.3M | 901k | 4.76 |
| 2020-03-31 | $3.7M | 1.0M | 3.57 |
| 2019-12-31 | $1.9M | 542k | 3.45 |
| 2019-09-30 | $2.4M | 592k | 4.01 |
| 2019-06-30 | $1.9M | 672k | 2.88 |
| 2019-03-31 | $4.2M | 606k | 6.87 |
| 2018-12-31 | $1.8M | 399k | 4.51 |
| 2018-09-30 | $3.2M | 422k | 7.62 |
| 2018-06-30 | $3.4M | 396k | 8.57 |
| 2018-03-31 | $3.1M | 421k | 7.29 |
| 2017-12-31 | $5.3M | 528k | 10.13 |
| 2017-06-30 | $3.0M | 267k | 11.26 |
| 2017-03-31 | $4.2M | 370k | 11.27 |
| 2016-12-31 | $3.2M | 319k | 9.90 |
| 2016-09-30 | $2.7M | 219k | 12.31 |
| 2016-06-30 | $6.2M | 213k | 29.05 |
| 2016-03-31 | $5.4M | 203k | 26.56 |
| 2015-12-31 | $7.1M | 203k | 35.12 |
| 2015-09-30 | $2.0M | 69k | 29.64 |
| 2015-06-30 | $1.0M | 25k | 41.67 |